Howe & Rusling’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.85M | Buy |
23,709
+1,000
| +4% | +$115K | 0.19% | 90 |
|
|
2025
Q4 | $2.39M | Buy |
22,709
+3,260
| +17% | +$306K | 0.16% | 91 |
|
|
2025
Q3 | $1.63M | Sell |
19,449
-125
| -0.6% | -$10.3K | 0.11% | 106 |
|
|
2025
Q2 | $1.55M | Sell |
19,574
-248
| -1% | -$19.7K | 0.11% | 107 |
|
|
2025
Q1 | $1.78M | Buy |
19,822
+760
| +4% | +$71K | 0.15% | 100 |
|
|
2024
Q4 | $1.9M | Sell |
19,062
-1,045
| -5% | -$108K | 0.16% | 97 |
|
|
2024
Q3 | $2.28M | Buy |
20,107
+893
| +5% | +$106K | 0.2% | 95 |
|
|
2024
Q2 | $2.38M | Buy |
19,214
+333
| +2% | +$42.9K | 0.22% | 93 |
|
|
2024
Q1 | $2.49M | Buy |
18,881
+144
| +0.8% | +$17.7K | 0.24% | 95 |
|
|
2023
Q4 | $2.04M | Buy |
18,737
+431
| +2% | +$44.7K | 0.22% | 95 |
|
|
2023
Q3 | $1.88M | Sell |
18,306
-356
| -2% | -$38.4K | 0.22% | 95 |
|
|
2023
Q2 | $2.15M | Buy |
18,662
+363
| +2% | +$41.2K | 0.24% | 96 |
|
|
2023
Q1 | $1.95M | Buy |
18,299
+2,640
| +17% | +$285K | 0.23% | 91 |
|
|
2022
Q4 | $1.74M | Sell |
15,659
-132
| -0.8% | -$13.5K | 0.22% | 86 |
|
|
2022
Q3 | $1.36M | Buy |
15,791
+913
| +6% | +$81.5K | 0.18% | 91 |
|
|
2022
Q2 | $1.36M | Buy |
14,878
+13,231
| +803% | +$1.17M | 0.17% | 95 |
|
|
2022
Q1 | $135K | Sell |
1,647
-215
| -12% | -$17K | 0.02% | 233 |
|
|
2021
Q4 | $143K | Sell |
1,862
-461
| -20% | -$36.7K | 0.02% | 221 |
|
|
2021
Q3 | $174K | Sell |
2,323
-4,931
| -68% | -$375K | 0.02% | 203 |
|
|
2021
Q2 | $564K | Sell |
7,254
-36,721
| -84% | -$2.73M | 0.07% | 110 |
|
|
2021
Q1 | $3.23M | Buy |
43,975
+841
| +2% | +$62K | 0.44% | 67 |
|
|
2020
Q4 | $3.37M | Sell |
43,134
-1,680
| -4% | -$128K | 0.51% | 59 |
|
|
2020
Q3 | $3.55M | Sell |
44,814
-126,331
| -74% | -$9.9M | 0.61% | 55 |
|
|
2020
Q2 | $12.6M | Buy |
171,145
+63,066
| +58% | +$4.75M | 2.33% | 10 |
|
|
2020
Q1 | $7.93M | Buy |
108,079
+106,396
| +6,322% | +$8.36M | 1.71% | 15 |
|
|
2019
Q4 | $146K | Buy |
1,683
+762
| +83% | +$62.6K | 0.02% | 208 |
|
|
2019
Q3 | $74K | Sell |
921
-1,048
| -53% | -$84K | 0.01% | 258 |
|
|
2019
Q2 | $158K | Buy |
1,969
+975
| +98% | +$74.7K | 0.03% | 213 |
|
|
2019
Q1 | $79K | Sell |
994
-325
| -25% | -$24.3K | 0.01% | 248 |
|
|
2018
Q4 | $96K | Sell |
1,319
-131
| -9% | -$9.25K | 0.02% | 208 |
|
|
2018
Q3 | $98K | Sell |
1,450
-366
| -20% | -$23.3K | 0.02% | 201 |
|
|
2018
Q2 | $105K | Sell |
1,816
-489
| -21% | -$27.6K | 0.02% | 197 |
|
|
2018
Q1 | $120K | Buy |
2,305
+259
| +13% | +$14K | 0.02% | 198 |
|
|
2017
Q4 | $110K | Buy |
2,046
+7
| +0.3% | +$388 | 0.02% | 235 |
|
|
2017
Q3 | $125K | Sell |
2,039
-490
| -19% | -$29.7K | 0.02% | 217 |
|
|
2017
Q2 | $155K | Sell |
2,529
-478
| -16% | -$29.1K | 0.03% | 166 |
|
|
2017
Q1 | $182K | Hold |
3,007
| – | – | 0.04% | 156 |
|
|
2016
Q4 | $169K | Sell |
3,007
-521
| -15% | -$30.5K | 0.04% | 153 |
|
|
2016
Q3 | $210K | Buy |
3,528
+313
| +10% | +$18.3K | 0.05% | 140 |
|
|
2016
Q2 | $177K | Buy |
3,215
+153
| +5% | +$8.14K | 0.04% | 142 |
|
|
2016
Q1 | $155K | Buy |
3,062
+892
| +41% | +$43.7K | 0.03% | 160 |
|
|
2015
Q4 | $109K | Buy |
2,170
+201
| +10% | +$10.1K | 0.03% | 197 |
|
|
2015
Q3 | $93K | Sell |
1,969
-199
| -9% | -$10.6K | 0.02% | 207 |
|
|
2015
Q2 | $118K | Buy |
2,168
+145
| +7% | +$8.13K | 0.03% | 201 |
|
|
2015
Q1 | $111K | Sell |
2,023
-2,679
| -57% | -$152K | 0.02% | 195 |
|
|
2014
Q4 | $255K | Sell |
4,702
-358
| -7% | -$19.9K | 0.06% | 136 |
|
|
2014
Q3 | $286K | Buy |
5,060
+441
| +10% | +$24.8K | 0.07% | 131 |
|
|
2014
Q2 | $255K | Sell |
4,619
-53
| -1% | -$2.89K | 0.06% | 141 |
|
|
2014
Q1 | $253K | Buy |
4,672
+113
| +2% | +$5.85K | 0.06% | 130 |
|
|
2013
Q4 | $218K | Buy |
4,559
+1,165
| +34% | +$53.3K | 0.05% | 138 |
|
|
2013
Q3 | $155K | Sell |
3,394
-1,258
| -27% | -$57.4K | 0.06% | 154 |
|
|
2013
Q2 | $206K | Buy |
+4,652
| New | +$208K | 0.06% | 155 |
|
Other funds holding MRK
VCM
VPM
Howe & Rusling's MRK Position: Q1 2026 in Review
Howe & Rusling increased its Merck (MRK) stake by 4.4% in Q1 2026, buying an estimated $115K and bringing the position to 23,709 shares worth $2.85M. The position accounts for 0.19% of the portfolio, ranked #90.
Howe & Rusling first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.6M in Q2 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Howe & Rusling held 23,709 shares of Merck worth $2.85M as of Q1 2026.
- Howe & Rusling bought 1,000 Merck shares in Q1 2026, an estimated $115K.
- Merck made up 0.19% of Howe & Rusling's portfolio in Q1 2026, its #90 holding.
- Howe & Rusling first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Howe & Rusling's Merck position peaked at $12.6M in Q2 2020.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.